Advertisement
"Listing our company on an exchange in Europe will help to grow ourshareholder base and better enable us to seek capital as well as marketingopportunities abroad," stated Eli Gonen, CEO of Cardio Vascular MedicalDevice Corp. "We have already received great interest from various parties inEurope for our patented guidewire, and are confident that our proprietarytechnology can aid in the performance of angioplasty procedures in developedcountries across the world."
Advertisement
About Cardio Vascular Medical Device
Cardio Vascular Medical Device holds a US patent for an innovativenext-generation "steerable guidewire" applicable for all angioplasty (PCTA)procedures. The technology hinges on a bendable tip that improves guidewireperformance, enables faster procedure completion, and provides cost benefitsfor patients as well as healthcare providers. The guidewire has a uniqueopportunity to become the guidewire of choice for surgeons throughout theworld.
Learn more about Cardio Vascular Medical Device at:http://www.cvslmedical.com
Forward-Looking Statements
This letter contains forward-looking statements within the meaning ofSection 27A of the Securities Act of 1933, as amended and Section 21E of theSecurities Exchange Act of 1934, as amended. All forward-looking statementsare inherently uncertain, based on current expectations and assumptionsconcerning future events or future performance of Cardio Vascular MedicalDevice Corp. and its technologies. In evaluating such statements, prospectiveinvestors should review carefully various risks and uncertainties identifiedin this release, as actual results may differ materially from those indicatedin the forward-looking statements. Cardio Vascular Medical Device Corp.public filings may be viewed at http://www.sec.gov.Contact: Alex Traiman Media Relations +1-646-863-9729 Asher Zwebner +972-54-464-6363 [email protected]
SOURCE Cardio Vascular Medicine Device Corp.
